About Us
Science Programs
Pipeline
Clinical Trials
Careers
cONTACT
Resources
Corporate Presentation
Posters, PRESENTATIONS & Publications
MEDIA
Events
News & press releases
Investors
Overview
Stock Information
Analyst Coverage
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Financials & SEC FILINGS
Sec Filings
Quarterly Results
cORPORATE GOVERNANCE
Management Team
Board of Directors
Committee Composition
Governance Documents
EVENT DETAILS
< Back to All Events
Rain Oncology Announces Topline Results from Phase 3 MANTRA Trial of Milademetan for the Treatment of Dedifferentiated Liposarcoma
May 22, 2023 8:30 AM
Click here for webcast
Description
Supporting materials
There are no supporting documents for this event
VIEW DOCUMENT
a
VIEW DOCUMENT
a
VIEW DOCUMENT
a
VIEW DOCUMENT
a
< Back to All Events
